Clinical Benefits and Utility of Pretherapeutic <i>DPYD</i> and <i>UGT1A1</i> Testing in Gastrointestinal Cancer

Authors

Institutions

Publication Details

Journal
JAMA Network Open
Published
2024-12-06
DOI
https://doi.org/10.1001/jamanetworkopen.2024.49441
Citations
17
Primary Topic
Cancer therapeutics and mechanisms
Type
article
Field-Weighted Citation Impact
3.97
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Clinical Benefits and Utility of Pretherapeutic DPYD and UGT1A1 Testing in Gastrointestinal Cancer

Michela Guardascione, Fabio Puglisi, Elena De Mattia, Alessia Bignucolo et al.
17 citations
JAMA Network Open
Cancer therapeutics and mechanisms
3.97
article

Clinical Benefits and Utility of Pretherapeutic DPYD and UGT1A1 Testing in Gastrointestinal Cancer

Michela Guardascione, Fabio Puglisi, Elena De Mattia, Alessia Bignucolo, Henk‐Jan Guchelaar, Elena Peruzzi, Adolfo Favaretto, Marcella Montico, Rossana Roncato, Jesse J. Swen, Erika Cecchin, Giuseppe Toffoli, Luisa Foltran, Mario D’Andrea
article en
17 citations

Abstract

No abstract available for this paper.
JAMA Network OpenVol. 7(12)
University of Udine (IT), Leiden University Medical Center (NL), AULSS 2 Marca Trevigiana (IT), Ospedale San Paolo (IT), Centro di Riferimento Oncologico (IT), Istituti di Ricovero e Cura a Carattere Scientifico (IT)
Good health and well-being
Openalex Percentile: Top 5%
Cancer therapeutics and mechanisms
3.97
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.